CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Contract with Customer, Liability, Current in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Charles River Laboratories International, Inc. quarterly Contract with Customer, Liability, Current history and growth rate from Q4 2017 to Q3 2024.
  • Charles River Laboratories International, Inc. Contract with Customer, Liability, Current for the quarter ending September 28, 2024 was $252M, a 0.59% increase year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $252M +$1.48M +0.59% Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $247M -$10.2M -3.97% Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $256M -$5.84M -2.23% Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $242M -$22.4M -8.49% Dec 30, 2023 10-Q 2024-11-06
Q3 2023 $250M -$988K -0.39% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $257M +$15.3M +6.33% Jul 1, 2023 10-Q 2023-08-09
Q1 2023 $262M +$34M +14.9% Apr 1, 2023 10-Q 2023-05-11
Q4 2022 $264M +$44.6M +20.3% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $251M +$29.7M +13.4% Sep 24, 2022 10-Q 2022-11-02
Q2 2022 $242M +$10.8M +4.65% Jun 25, 2022 10-Q 2022-08-03
Q1 2022 $228M +$15.2M +7.15% Mar 26, 2022 10-Q 2022-05-04
Q4 2021 $220M +$11.8M +5.66% Dec 25, 2021 10-K 2023-02-22
Q3 2021 $222M +$49.4M +28.7% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 $231M +$60.9M +35.7% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 $213M +$34.2M +19.1% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 $208M +$36.1M +21% Dec 26, 2020 10-K 2022-02-16
Q3 2020 $172M +$6.24M +3.76% Sep 26, 2020 10-Q 2020-11-09
Q2 2020 $170M +$2.88M +1.72% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 $179M +$40.9M +29.7% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 $172M +$26.7M +18.4% Dec 28, 2019 10-K 2021-02-17
Q3 2019 $166M +$25.3M +18% Sep 28, 2019 10-Q 2019-11-06
Q2 2019 $168M +$37.1M +28.5% Jun 29, 2019 10-Q 2019-07-31
Q1 2019 $138M Mar 30, 2019 10-Q 2019-05-07
Q4 2018 $145M +$27.6M +23.5% Dec 29, 2018 10-K 2020-02-11
Q3 2018 $141M Sep 29, 2018 10-Q 2018-11-07
Q2 2018 $130M Jun 30, 2018 10-Q 2018-08-08
Q4 2017 $118M Dec 30, 2017 10-K 2019-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.